Literature DB >> 12409177

Prior poliomyelitis-evidence of cytokine production in the central nervous system.

Henrik Gonzalez1, Mohsen Khademi, Magnus Andersson, Erik Wallström, Kristian Borg, Tomas Olsson.   

Abstract

In order to study the role of a possible inflammatory reaction in the post-polio syndrome (PPS) four key cytokines were determined by means of mRNA expression in mononuclear cells from cerebrospinal fluid (CSF) and peripheral blood of 13 patients. Data were compared with those of samples from eight non-inflammatory control persons. The PPS-patients displayed increased numbers of CSF cells expressing mRNA for TNF-alpha (p<0.02), IFN-gamma (p<0.02), IL-4 (p<0.001) and IL-10 (p<0.05), in comparison to the non-inflammatory controls. As positive controls, samples from patients with Multiple Sclerosis (MS) were examined. We conclude that there is a chronic intra CNS expression of inflammatory cytokines in PPS, in the range of that in MS, a well known neuroinflammatory disease. However, the pathogenic significance of this is unclear.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12409177     DOI: 10.1016/s0022-510x(02)00316-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  IVIG treatment in post-polio patients: evaluation of responders.

Authors:  Gunilla Ostlund; Lisbet Broman; Lars Werhagen; Kristian Borg
Journal:  J Neurol       Date:  2012-05-17       Impact factor: 4.849

Review 2.  Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects.

Authors:  Marinos C Dalakas
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

3.  Update on current and emerging treatment options for post-polio syndrome.

Authors:  Elisabeth Farbu
Journal:  Ther Clin Risk Manag       Date:  2010-07-21       Impact factor: 2.423

Review 4.  IVIg in other autoimmune neurological disorders: current status and future prospects.

Authors:  Marinos Dalakas
Journal:  J Neurol       Date:  2008-07       Impact factor: 4.849

5.  Post-Polio Syndrome.

Authors:  Bruk Jubelt
Journal:  Curr Treat Options Neurol       Date:  2004-03       Impact factor: 3.598

6.  Intravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up.

Authors:  Henrik Gonzalez; Mohsen Khademi; Kristian Borg; Tomas Olsson
Journal:  J Neuroinflammation       Date:  2012-07-09       Impact factor: 8.322

7.  Elevated blood lipids are uncommon in patients with post-polio syndrome--a cross sectional study.

Authors:  Eva Melin; Thomas Kahan; Kristian Borg
Journal:  BMC Neurol       Date:  2015-04-29       Impact factor: 2.474

Review 8.  Effectiveness of Intravenous Immunoglobulin for Management of Pain in Patients with Postpolio Syndrome.

Authors:  Min Cheol Chang; Jin-Sung Park; Jong-Moon Hwang; Donghwi Park
Journal:  Pain Res Manag       Date:  2021-03-20       Impact factor: 3.037

9.  Normal serum levels of immune complexes in postpolio patients.

Authors:  Eva Melin; Azita Sohrabian; Johan Rönnelid; Kristian Borg
Journal:  Results Immunol       Date:  2014-06-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.